“Safety of Subcutaneous Immunotherapy With Tyrosine-Adsorbed House Dust Mite Extracts in Patients With Allergic Disease”. Revista Alergia México 64, no. 1 (February 9, 2017): 52–65. Accessed September 23, 2026. https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/233.